AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesNCT04968665

The Mechanism for the Effects of Joint Biomechanical Properties on Medial Cartilage of Tibiofemoral Joint Degeneration

An observational study of Anterior Cruciate Ligament Injuries and Cartilage Degeneration, run by Peking University Third Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Explore The Mechanism for the Effects of Joint Biomechanical Properties on Medial Cartilage of Tibiofemoral Joint Degeneration Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
What is being tested?
gait testing, functional MRI
How many people
60 participants
Where
No sites listed yet
Study dates
1 Aug 2021to 1 Jan 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Thirty patients with ACL rupture undergoing ACL reconstruction surgery at the Institute of Sports Medicine, Peking University Third Hospital would be included in the study cohort were included, A total of 30 healthy volunteers with no history of musculoskeletal system injury or surgery in bilateral lower extremities would be included

Who may be able to join

  • Unilateral ACL rupture of the knee

Who cannot join

  • concomitant with other ligament injury or rupture, with history of surgery or musculoskeletal system injury of the contralateral knee, and the time from injury to operation more than 8 weeks

Trial locations and contacts

No sites are listed yet.

About this study

Explore The Mechanism for the Effects of Joint Biomechanical Properties on Medial Cartilage of Tibiofemoral Joint Degeneration

Read the detailed description

Cartilage degeneration in the medial tibiofemoral joint is common after anterior cruciate ligament reconstruction (ACLR), which may develop into knee osteoarthritis (disability rate 21.3%). Alterations in joint biomechanical properties play an important role in cartilage degeneration after ACLR. However, the mechanism remains unclear.

Our research studied the joint kinematics and kinetics properties after ACLR and found significant changes in biomechanics in the ACLR knees. Therefore, this study will combine longitude biochemical changes in the cartilage to explore how the alterations in biomechanics would influence biochemical changes in the joint cartilage.

This study will explore the joint biomechanical properties during functional activities by motion analysis, the effects of biomechanical properties on cartilage stress distribution by finite element analysis, the long-term biochemical changes in the joint cartilage by functional MRI. This study will establish prediction models for cartilage biomechanical changes in the mid-term based on joint biomechanical properties in the early stage after ACLR, and cartilage biomechanical changes in the long-term based on joint biomechanical properties in the mid-term after ACLR. The study aims to clarify the mechanism of cartilage degeneration after ACLR and search biomechanical risk factors, in order to provide methods for clinical prevention of cartilage degeneration after ACLR.

Being tested
gait testing, functional MRI
Keywords
sports biomechanics, joint loading, anterior cruciate ligament reconstruction, cartilage degeneration, functional MRI
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • gait testing, functional MRIDiagnostic test

    diagnostic tests including the gait testing and functional MRI

Study groups in NCT04968665
Study groupRoleWhat they receive
healthy volunteersgait testing and MRI at baseline for healthy volunteers
Receives: Diagnostic Test: gait testing, functional MRI
ACL-deficient patientsgait testing and MRI at pre-operation, 6 months post-operation, 1 year post-operation, 2 years post-operation
Receives: Diagnostic Test: gait testing, functional MRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. knee T1 rho value

    knee T1 rho value by functional MRI

    Measured: On the day of enrollment.

  2. knee T1 rho value

    knee T1 rho value by functional MRI

    Measured: At 6 months post operation.

  3. knee T1 rho value

    knee T1 rho value by functional MRI

    Measured: At 12 months post operation.

  4. knee T1 rho value

    knee T1 rho value by functional MRI

    Measured: At 2 years post operation.

  5. knee T2 value

    knee T1 rho value by functional MRI

    Measured: On the day of enrollment.

  6. knee T2 value

    knee T1 rho value by functional MRI

    Measured: At 6 months post operation.

  7. knee T2 value

    knee T1 rho value by functional MRI

    Measured: At 12 months post operation.

  8. knee T2 value

    knee T1 rho value by functional MRI

    Measured: At 2 years post operation.

  9. knee extension angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: On the day of enrollment.

  10. knee extension angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 6 months post operation.

  11. knee extension angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 12 months post operation.

  12. knee extension angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 2 years post operation.

  13. knee moments

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: On the day of enrollment.

  14. knee moments

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 6 months post operation.

  15. knee moments

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 12 months post operation.

  16. knee moments

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 2 years post operation.

  17. ground reaction force

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: On the day of enrollment.

  18. ground reaction force

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 6 months post operation.

  19. ground reaction force

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 12 months post operation.

  20. ground reaction force

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 2 years post operation.

  21. knee rotation angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: On the day of enrollment.

  22. knee rotation angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 6 months post operation.

  23. knee rotation angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 12 months post operation.

  24. knee rotation angles

    Three-dimensional gait analysis system and plantar pressure were used during walking, running, cutting and jumping

    Measured: At 2 years post operation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2021
  2. Study start1 Aug 2021 (estimated)
  3. Primary completion1 Jan 2022 (estimated)
  4. Study completion1 Jan 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04968665
Sponsor's protocol ID
M2019434
Status last verified
Jul 2021
First submitted
2 Jul 2021
Last updated
20 Jul 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anterior Cruciate Ligament Injuries and Cartilage Degeneration, run by Peking University Third Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shuang Ren (+8617610252992, xixishuang123@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

knee T1 rho value (time frame: On the day of enrollment.). The study lists 24 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in